AD-227B
- Generic Name
- AD-227B
A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B
Phase 3
Recruiting
- Conditions
- Essential Hypertension
- Interventions
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 251
- Registration Number
- NCT06441630
- Locations
- 🇰🇷
Gangnam CHA Medical Center, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath